Inhibition of the RAC Activator VAV3 by the small molecule IODVA1 impedes RAC signaling & overcomes resistance to tyrosine kinase inhibition in lymphoblastic leukemia.

被引:0
|
作者
Nassar, Nicolas N. [1 ]
Hegde, Shailaja [1 ]
Wunderlich, Kark [1 ]
Lin, Yuan [1 ]
Ahmadian, Reza [2 ]
Seibel, William [1 ]
Zheng, Yi [1 ]
Mizukawa, Benjamin E. [1 ]
Vinnedge, Lisa Privette [1 ]
Cancelas, Jose A. [1 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
[2] Heinrich Heine Univ, Dusseldorf, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB198
引用
收藏
页数:1
相关论文
共 15 条
  • [1] Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia
    Hegde, Shailaja
    Gasilina, Anjelika
    Wunderlich, Mark
    Lin, Yuan
    Buchholzer, Marcel
    Krumbach, Oliver H. F.
    Akbarzadeh, Mohammad
    Ahmadian, Mohammad Reza
    Seibel, William
    Zheng, Yi
    Perentesis, John P.
    Mizukawa, Benjamin E.
    Vinnedge, Lisa Privette
    Cancelas, Jose A.
    Nassar, Nicolas N.
    LEUKEMIA, 2022, 36 (03) : 637 - 647
  • [2] Inhibition of the RacGEF VAV3 by the small molecule IODVA1 impedes RAC signaling and overcomes resistance to tyrosine kinase inhibition in acute lymphoblastic leukemia
    Shailaja Hegde
    Anjelika Gasilina
    Mark Wunderlich
    Yuan Lin
    Marcel Buchholzer
    Oliver H. F. Krumbach
    Mohammad Akbarzadeh
    Mohammad Reza Ahmadian
    William Seibel
    Yi Zheng
    John P. Perentesis
    Benjamin E. Mizukawa
    Lisa Privette Vinnedge
    José A. Cancelas
    Nicolas N. Nassar
    Leukemia, 2022, 36 : 637 - 647
  • [3] The Small Molecule IODVA1 Inhibits the Rac Guanine Nucleotide Exchange Factor Vav3 and Overcomes TKI-Resistance in Ph+(BCR-ABL1) B-ALL
    Nassar, Nicolas
    Hegde, Shailaja N.
    Gasilina, Anjelika
    Wunderlich, Mark
    Premnauth, Gurdat
    Merino, Edward
    Lin, Yuan
    Ahmadian, Reza
    Zheng, Yi
    Mizukawa, Benjamin
    Vinnedge, Lisa Privette
    Cancelas, Jose A.
    BLOOD, 2019, 134
  • [4] PTP1B Inhibition Causes Rac1 Activation by Enhancing Receptor Tyrosine Kinase Signaling
    Tsuchiya, Ayako
    Kanno, Takeshi
    Nagaya, Hisao
    Shimizu, Tadashi
    Tanaka, Akito
    Nishizaki, Tomoyuki
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2014, 33 (04) : 1097 - 1105
  • [5] Structural mechanism for the inhibition of Abelson tyrosine kinase by a small molecule inhibitor that is effective in the treatment of chronic myelogenous leukemia.
    Schindler, T
    Vidal, E
    Bornmann, WG
    Pellicena, P
    Miller, WT
    Clarkson, B
    Kuriyan, J
    CLINICAL CANCER RESEARCH, 2000, 6 : 4544S - 4544S
  • [6] TWIST1 inhibition overcomes resistance to tyrosine kinase inhibitors in MET driven non-small cell lung cancer
    Kumar, Vinod
    Yochum, Zachary A.
    Devadassan, Princey
    Huang, Eric
    Miller, Ethan
    Ayyala, Vasavi
    Stabile, Laura P.
    Burns, Timothy F.
    Rumde, Purva H.
    CANCER RESEARCH, 2022, 82 (12)
  • [7] Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
    Weisberg, E
    Boulton, C
    Kelly, LM
    Manley, P
    Fabbro, D
    Meyer, T
    Gilliland, DG
    Griffin, JD
    CANCER CELL, 2002, 1 (05) : 433 - 443
  • [8] Gallic acid inhibition of Src-Stat3 signaling overcomes acquired resistance to EGF receptor tyrosine kinase inhibitors in advanced non-small cell lung cancer
    Phan, Ai N. H.
    Hua, Tuyen N. M.
    Kim, Min-kyu
    Vo, Vu T. A.
    Choi, Jong-Whan
    Kim, Hyun-Won
    Rho, Jin Kyung
    Kim, Ki Woo
    Jeong, Yangsik
    ONCOTARGET, 2016, 7 (34) : 54702 - 54713
  • [9] Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia
    Zeng, ZH
    Samudio, IJ
    Zhang, WG
    Estrov, Z
    Pelicano, H
    Harris, D
    Frolova, O
    Hail, N
    Chen, WJ
    Kornblau, SM
    Huang, P
    Lu, YL
    Mills, GB
    Andreeff, M
    Konopleva, M
    CANCER RESEARCH, 2006, 66 (07) : 3737 - 3746
  • [10] The tyrosine phosphatase SHP-1 downregulates endothelial NAD(P)H-oxidase activity through Pl3-kinase dependent inhibition of Rac1
    Krötz, F
    Engelbrecht, B
    Bridell, H
    Buerkle, MA
    Bassermann, F
    Gloe, T
    Schiele, TM
    Klauss, V
    Pohl, U
    Sohn, HY
    CIRCULATION, 2004, 110 (17) : 158 - 158